Teriparatide Injection for Osteoporosis Research:CAGR of 9.25% during the forecast period

Teriparatide Injection for Osteoporosis Market Summary

According to the new market research report "Global Teriparatide Injection for Osteoporosis Market Report 2024-2030", published by QYResearch, the global Teriparatide Injection for Osteoporosis market size is projected to reach USD 4.12 billion by 2030, at a CAGR of 9.25% during the forecast period.



Global Teriparatide Injection for Osteoporosis MarketSize(US$ Million), 2019-2030
240914-170915.webp (14 KB)

Above data is based on report from QYResearch: Global Teriparatide Injection for Osteoporosis Market Report 2024-2030 (published in 2024). If you need the latest data, plaese contact QYResearch.



Global Teriparatide Injection for Osteoporosis Top7Players Ranking and Market Share (Ranking is based on the revenue of 2023, continually updated)
240914-170943.webp (19 KB)

Above data is based on report from QYResearch: Global Teriparatide Injection for Osteoporosis Market Report 2024-2030 (published in 2024). If you need the latest data, plaese contact QYResearch.

According to QYResearch Top Players Research Center, the global key manufacturers of Teriparatide Injection for Osteoporosis include Shenzhen Salubris Pharmaceuticals, Asahi Kasei, Ligand Pharmaceuticals, Eli Lilly and Company, Alvogen, etc. In 2023, the global top four players had a share approximately 84.00% in terms of revenue, the global top three players had a share approximately 67.00% in terms of revenue.

Teriparatide Injection for Osteoporosis,Global Market Size, Split by Product Segment
240914-171008.webp (18 KB)





Based on or includes research from QYResearch: Global Teriparatide Injection for Osteoporosis Market Report 2024-2030.

In terms of product type, currently Manual Injection is the largest segment, hold a share of 54.13%.



In terms of product application, currently Female is the largest segment, hold a share of 76.54%.



Market Drivers:

With the increasing trend of population aging, the number of osteoporosis patients is increasing. The huge patient population provides a broad market space for anti-osteoporosis drugs such as teriparatide. At the same time, as a bone synthesis agent, teriparatide can directly act on osteoblasts, promote new bone synthesis, and rebuild bones, with significant therapeutic effects. Secondly, governments of various countries pay more and more attention to medical health, and increase support for the prevention and treatment of chronic diseases such as osteoporosis, which provides a good policy environment for the research, development, production and sales of teriparatide injection for osteoporosis.

Restraint:

Teriparatide injection for osteoporosis is expensive and has certain side effects. Long-term use may also lead to adverse reactions such as abnormal blood coagulation and arrhythmia. There are currently many anti-osteoporosis drugs on the market, which have a certain competitive relationship with teriparatide.

Opportunity:

As the population continues to age, the number of osteoporosis patients will continue to increase, providing a long-term and stable market demand for teriparatide injection for osteoporosis. With the continuous advancement and innovation of medical technology, the research and development and production process of teriparatide injection for osteoporosis are being continuously optimized and improved.

About QYResearch

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 17 years' experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let's work closely with you and build a bold and better future.

QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)  
JP: https://www.qyresearch.co.jp

This release was published on openPR.